Times to treatment in transfer patients undergoing primary percutaneous coronary intervention in the United States - National Registry of Myocardial Infarction (NRMI)-3/4 analysis

被引:378
作者
Nallamothu, BK
Bates, ER
Herrin, J
Wang, YF
Bradley, EH
Krumholz, HM
机构
[1] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, Sect Hlth Policy & Adm, New Haven, CT 06520 USA
[2] Yale Univ, Sch Med, Dept Internal Med, Sect Vasc Med, New Haven, CT 06520 USA
[3] Ann Arbor Vet Affairs Med Ctr, Hlth Serv Res & Dev Ctr Excellence, Ann Arbor, MI USA
[4] Univ Michigan, Sch Med, Dept Internal Med, Div Cardiovasc Dis, Ann Arbor, MI USA
[5] Flying Buttress Associates, Charlottesville, VA USA
关键词
catheterization; myocardial infarction; angioplasty; health policy;
D O I
10.1161/01.CIR.0000155258.44268.F8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background - Treatment delays in patients with ST-segment - elevation myocardial infarction ( STEMI) transferred for primary percutaneous coronary intervention (PCI) may decrease the advantage of this strategy over on-site fibrinolytic therapy that has been demonstrated in recent clinical trials. Accordingly, we sought to describe patterns of times to treatment in patients undergoing interhospital transfer for primary PCI in the United States. Methods and Results - We analyzed patients with STEMI undergoing interhospital transfer for primary PCI between January 1999 and December 2002 in the National Registry of Myocardial Infarction. The primary outcome was "total" door-to-balloon time measured from time of arrival at the initial hospital to time of balloon inflation at the PCI hospital. Multivariable hierarchical models were used to assess the relationship of total door-to-balloon time with patient and hospital characteristics. Among 4278 patients transferred for primary PCI at 419 hospitals, the median total door-to-balloon time was 180 minutes, with only 4.2% of patients treated within 90 minutes, the benchmark recommended by national quality guidelines. Comorbid conditions, absence of chest pain, delayed presentation after symptom onset, less specific ECG findings, and hospital presentation during off-hours were associated with longer total door-to-balloon times. Patients at teaching hospitals in rural areas also had significantly longer times to treatment. Conclusions - Total door-to-balloon times for transfer patients undergoing primary PCI in the United States rarely achieve guideline-recommended benchmarks, and current decision making should take these times into account. For the full benefits of primary PCI to be realized in transfer patients, improved systems are urgently needed to minimize total door-to-balloon times.
引用
收藏
页码:761 / 767
页数:7
相关论文
共 32 条
  • [1] Task force 1: The ACCF and AHA codes of conduct in human subjects research
    Adams, RJ
    Antman, EM
    Kavey, REW
    [J]. CIRCULATION, 2004, 110 (16) : 2512 - 2516
  • [2] *AM HOSP ASS, 2000, ANN SURV HOSP DAT DO
  • [3] A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction
    Andersen, HR
    Nielsen, TT
    Rasmussen, K
    Thuesen, L
    Kelbaek, H
    Thayssen, P
    Abildgaard, U
    Pedersen, F
    Madsen, JK
    Grande, P
    Villadsen, AB
    Krusell, LR
    Haghfelt, T
    Lomholt, P
    Husted, SE
    Vigholt, E
    Kjaergard, HK
    Mortensen, LS
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (08) : 733 - 742
  • [4] Predictors of door-to-balloon delay in primary angioplasty
    Angeja, BG
    Gibson, CM
    Chin, R
    Frederick, PD
    Every, NR
    Ross, AM
    Stone, GW
    Barron, HV
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2002, 89 (10) : 1156 - 1161
  • [5] Pharmacoinvasive therapy - The future of treatment for ST-elevation myocardial infarction
    Antman, EM
    Van de Werf, F
    [J]. CIRCULATION, 2004, 109 (21) : 2480 - 2486
  • [6] INDICATIONS FOR FIBRINOLYTIC THERAPY IN SUSPECTED ACUTE MYOCARDIAL-INFARCTION - COLLABORATIVE OVERVIEW OF EARLY MORTALITY AND MAJOR MORBIDITY RESULTS FROM ALL RANDOMIZED TRIALS OF MORE THAN 1000 PATIENTS
    APPLEBY, P
    BAIGENT, C
    COLLINS, R
    FLATHER, M
    PARISH, S
    PETO, R
    BELL, P
    HALLS, H
    MEAD, G
    DIAZ, R
    PAOLASSO, E
    PAVIOTTI, C
    ROMERO, G
    CAMPBELL, T
    OROURKE, MF
    THOMPSON, P
    LESAFFRE, E
    VANDEWERF, F
    VERSTRAETE, M
    ARMSTRONG, PW
    CAIRNS, JA
    MORAN, C
    TURPIE, AG
    YUSUF, S
    GRANDE, P
    HEIKKILA, J
    KALA, R
    BASSAND, JP
    BOISSEL, JP
    BROCHIER, M
    LEIZOROVICZ, A
    BRUGGEMANN, T
    KARSCH, KR
    KASPER, W
    LAMMERTS, D
    NEUHAUS, KL
    MEYER, J
    SCHRODER, R
    VONESSEN, R
    SARAN, RK
    ARDISSINO, D
    BONADUCE, D
    BRUNELLI, C
    CERNIGLIARO, C
    FORESTI, A
    FRANZOSI, MG
    GUIDUCCI, D
    MAGGIONI, A
    MAGNANI, B
    MATTIOLI, G
    [J]. LANCET, 1994, 343 (8893) : 311 - 322
  • [7] Relationship between delay in performing direct coronary angioplasty and early clinical outcome in patients with acute myocardial infarction - Results from the Global Use of Strategies to Open Occluded Arteries in Acute Coronary Syndromes (GUSTO-IIb) Trial
    Berger, PB
    Ellis, SG
    Holmes, DR
    Granger, CB
    Criger, DA
    Betriu, A
    Topol, EJ
    Califf, RM
    [J]. CIRCULATION, 1999, 100 (01) : 14 - 20
  • [8] Betriu A, 1997, NEW ENGL J MED, V336, P1621
  • [9] Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction
    Cannon, CP
    Gibson, CM
    Lambrew, CT
    Shoultz, DA
    Levy, D
    French, WJ
    Gore, JM
    Weaver, WD
    Rogers, WJ
    Tiefenbrunn, AJ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (22): : 2941 - +
  • [10] The volume of primary angioplasty procedures and survival after acute myocardial infarction
    Canto, JG
    Every, NR
    Magid, DJ
    Rogers, WJ
    Malmgren, JA
    Frederick, PD
    French, WJ
    Tiefenbrunn, AJ
    Misra, VK
    Kiefe, CI
    Barron, HV
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (21) : 1573 - 1580